• Return to Headlines

Biogen Inc has the Highest Sales per Share in the Biotechnology Industry (BIIB, REGN, UTHR, AMGN, GILD)

By Shiri Gupta

Below are the three companies in the Biotechnology industry with the highest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.

Biogen Inc ranks highest with a sales per share of $53.01. Following is Regeneron Pharm with a sales per share of $47.39. United Therapeut ranks third highest with a sales per share of $36.78.

Amgen Inc follows with a sales per share of $30.81, and Gilead Sciences rounds out the top five with a sales per share of $22.03.

SmarTrend recommended that subscribers consider buying shares of Biogen Inc on June 12th, 2017 as our technology indicated a new Uptrend was in progress when shares hit $262.53. Since that recommendation, shares of Biogen Inc have risen 22.3%. We continue to monitor Biogen Inc for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: highest sales per share biogen inc regeneron pharm united therapeut amgen inc Gilead Sciences

Ticker(s): BIIB REGN UTHR AMGN GILD